Tdap Booster

A booster dose combining tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis antigens. Given in adolescence to maintain immunity waning from childhood DPT and protect against whooping cough.

The Tdap Booster is recommended for 10–12 years (booster). It falls under the Adolescent vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Tdap Booster has an efficacy of 80–90%. This means it provides significant protection against Diphtheria and Pertussis (Whooping Cough). Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Pain; redness; swelling at injection site; mild fever. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Tdap Booster should be avoided by: Severe allergy to a previous tetanus or diphtheria-containing vaccine; encephalopathy within 7 days of prior pertussis vaccine. Always inform your healthcare provider of your full medical history before vaccination.

The Tdap Booster typically costs ₹800 – ₹2,000 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.